Skip to content
Recall Observatory FDA recall evidence

Drug product

quinapril HCl/hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0223-1

D-0760-2022

March 21, 2022

Class II

Product summary

Firm
Pfizer Inc.
Event
Event 89864
Status
Terminated
Classification
Class II
Quantity
1104 bottles
Official record key
drug-enforcement:D-0760-2022

Official wording

Reason: CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.

Code information: Lot DP3414; Exp 02/2023

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-nitroso-hydrochlorothiazide impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations